Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study-Reference-Cited by-同舟云学术

Treatment of advanced nasopharyngeal cancer using low- or high-dose concurrent chemoradiotherapy with intensity-modulated radiotherapy: A propensity score-matched, nationwide, population-based cohort study

Published:2018-10 Issue:1 Volume:129 Page:23-29
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Chen Tsung-Ming,Lin Kuan-Chou,Yuan Kevin Sheng-Po,Chang Chia-Lun,Chow Jyh-Ming,Wu Szu-Yuan

Funder

Taipei Medical University

Wan Fang Hospital

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference44 articles.

1. Nasopharyngeal carcinoma in Taiwan. Clinical manifestations and results of therapy;Hsu;Cancer,1983

2. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan;Hsu;Cancer Epidemiol Biomarkers Prev,2009

3. Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: implication from age-period-cohort analysis;Hsu;Cancer Epidemiol Biomarkers Prev,2006

4. National Health Insurance Administration, Ministry of Health and Welfare, Taiwan, R.O.C. (2014). National Health Insurance Annual Report 2014–2015; 2016.

5. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories;Ma;Clin Cancer Res,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin use reduces radiation-induced stroke risk in advanced nasopharyngeal carcinoma patients;Radiotherapy and Oncology;2024-02

2. Transcriptomic analysis reveals differential adaptation of colorectal cancer cells to low and acute doses of cisplatin;Gene;2023-05

3. Impact of Chronic Obstruction Pulmonary Disease on Survival in Patients with Advanced Stage Lung Squamous Cell Carcinoma Undergoing Concurrent Chemoradiotherapy;Cancers;2021-06-28

4. Neoadjuvant Chemotherapy or Endocrine Therapy for Invasive Ductal Carcinoma of the Breast With High Hormone Receptor Positivity and Human Epidermal Growth Factor Receptor 2 Negativity;JAMA Network Open;2021-03-12

5. Pathologic response rates for breast cancer stages as a predictor of outcomes in patients receiving neoadjuvant chemotherapy followed by breast-conserving surgery;Surgical Oncology;2021-03